Olaparib Treatment in BRCA Mutated Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy | MicrobiomeTrials← Back to trialsNCT01874353
Olaparib Treatment in BRCA Mutated Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy
RecruitingPHASE3INTERVENTIONAL
Trial Details
Start: 2013-09-03Est. Completion: 2016-09-19
Enrollment target: 327 participants Locations- University of Alabama at Birmingham, Birmingham, Alabama, United States
- Palo Alto Foundation Medical Group, San Francisco, California, United States
- University of Colorado, Aurora, Colorado, United States
- The Hospital of Central Connecticut, New Britain, Connecticut, United States
- Gynecologic Cancer Center, Orlando, Florida, United States
- North Shore University, Evanston, Illinois, United States
- Greater Baltimore Medical Center, Baltimore, Maryland, United States
- Johns Hopkins, Baltimore, Maryland, United States
- Dana Farber Cancer Institute, Boston, Massachusetts, United States
- Massachusetts General Hospital, Boston, Massachusetts, United States
- MD Anderson at Cooper Cancer Center, Voorhees Township, New Jersey, United States
- Womens Cancer Care Associates, Albany, New York, United States
- Winthrop Gynecologic Oncology Associates, Mineola, New York, United States
- OSU JamesCare at Mill Run, Hilliard, Ohio, United States
- Henry Joyce Cancer Clinic, Nashville, Tennessee, United States
- Aurora St Lukes Medical Center, Milwaukee, Wisconsin, United States
Other microbiome trials you might be interested in
Carcinoma, NeuroendocrineTumor, NeuroendocrineTumors, NeuroendocrineNeuroendocrine; CarcinomaSmall Cell; Receptors
Background:
High-grade neuroendocrine carcinomas (HGNEC) are cancers that develop in different parts of the body, inclu…
Bethesda, United StatesEst. completion Jul 30, 2027
Biliary Tract Cancer
A study to assess the safety and efficacy of durvalumab in combination with gemcitabine-based chemotherapy regimens in p…
Mobile, United StatesEst. completion Oct 2, 2025
Mercy Hospital for Women, Heidelberg, AustraliaThe Royal Womens Hospital, Parkville, AustraliaPrince of Wales Hospital, Randwick, AustraliaU.Z. Gent, Ghent, BelgiumUZ Leuven Gasthuisberg, Leuven, BelgiumCentro Diagnóstico Barretos, Barretos, BrazilCentro Regional Integrado de Oncologia, Fortaleza, BrazilHospital Araujo Jorge, Goiânia, BrazilHospital de Caridade de Ijuí, Ijuí, BrazilCentro de Novos Tratamentos Itajai, Itajaí, BrazilHospital de Clinicas de Porto Alegre, Porto Alegre, BrazilIrmandade da Santa Casa de Misericordia de Porto Alagre, Porto Alegre, BrazilHospital de Base São José do Rio Preto, São José do Rio Preto, BrazilCentro de Referencia da Saude da Mulher, São Paulo, BrazilInstituto do Câncer de São Paulo, São Paulo, BrazilJuravinski Cancer Centre, Hamilton, Ontario, CanadaLondon Health Sciences Centre, London, Ontario, CanadaPrincess Margaret Cancer Centre, Toronto, Ontario, CanadaSunnybrook Health Sciences Center, Toronto, Ontario, CanadaCHUM - Hopital Norte-Dame, Montreal, Quebec, CanadaHotel-Dieu de Quebec, Québec, Quebec, CanadaCHUS Site Fleurimont, Sherbrooke, Quebec, CanadaBeijing Cancer Hospital, Beijing, ChinaThe Tumor Hospital affiliated to China Medical Science Insti, Beijing, China1st Hospital of Jilin university, Changchun, ChinaJilin Provincial Cancer Hospital, Changchun, ChinaHunan Cancer Hospital, Changsha, ChinaWest China Hospital Affiliated to Sichuan University, Chengdu, ChinaChongQing Cancer Hospital, Chongqing, ChinaResearch Site, Guangzhou, ChinaWomen's Hospital, Zhejaing University School of Medicine, Hangzhou, ChinaThe Tumour Hospital of Harbin Medical University, Harbin, ChinaZhejiang Cancer Hospital, Huangzhou, Huangzhou, ChinaJINAN, Qi Lu Hosp. of SD Univ., Jinan, ChinaResearch Site, Shanghai, ChinaShanghai Cancer Hospital of Fudan University, Shanghai, ChinaThe First Affiliated Hospital of Soochow University, Suzhou, ChinaFirst affiliated hospital college of XianJiaotong University, Xi'an, ChinaInstitut Bergonie, Bordeaux, FranceCAC François Baclesse, Caen, France69LYON, C Bérard, Onco, Lyon, FranceCentre Catherine de Sienne, Nantes, France75PARIS, H Tenon, Onco, Paris, FranceHopital Européen Georges Pompidou, Paris, FranceInstitut Curie Paris Et Saint Cloud, Paris, France69PIERREBE, CH Lyon Sud,, Pierre-Bénite, France92STCLOUD, C Huguenin, Onco, Saint-Cloud, FranceInstitut Claudius Regaud, Toulouse, FranceCentre Alexis Vautrin, Vandœuvre-lès-Nancy, FranceInstitut Gustave Roussy, Villejuif, FranceHelios-Kliniken Berlin - Buch, Berlin, GermanyFriedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, GermanyKlinikum Essen-Mitte,Evang. Huyssens-Stiftung/Knapps gGmbH, Essen, GermanyJohann-Wolfgang Goethe-Universität, Frankfurt, GermanyMedizinische Hochschule Hannover, Hanover, GermanyUniversitätsklinikum Schleswig-Holstein, Lübeck, GermanyKlinikum rechts der Isar der Technischen Universität, München, GermanyOnkologie Ravensburg, Ravensburg, GermanyUniversitätsklinikum Rostock, Rostock, GermanyRambam Health Care Campus, Haifa, IsraelSapir Medical Centre, Kfar Saba, IsraelTel Hashomer, Ramat Gan, IsraelIstituto Europeo di Oncologia, Milan, ItalyAzienda Ospedaliera Policlinico Di Modena, Modena, ItalyIstituto Nazionale Tumori Fondazione Pascale, Naples, ItalyIstituto Oncologico Veneto Irccs, Padova, ItalyIstituto Regina Elena-Polo Oncologico Ifo, Roma, ItalyPoliclinico Universitario A. Gemelli, Roma, ItalyHyogo Cancer Center, Akashi-shi, JapanNational Cancer Center Hospital, Chūōku, JapanNational Hospital Organization Kyushu Cancer Center, Fukuoka, JapanSaitama Medical University International Medical Center, Hidaka-shi, JapanNational Hospital Organization Shikoku Cancer Center, Matsuyama, JapanNiigata University Medical and Dental Hospital, Niigata, JapanKindai University Hospital, Osakasayama-shi, JapanHokkaido University Hospital, Sapporo, JapanShizuoka Cancer Center, Sunto-gun, JapanNetherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Amsterdam, NetherlandsMaastricht Universitair Medisch Centrum, Maastricht, NetherlandsUniversitair Medisch Centrum St. Radboud, Nijmegen, NetherlandsErasmus Medisch Centrum, Rotterdam, NetherlandsNiepubliczny Zaklad Opieki Zdrowotnej Innowacyjna Medycyna, Grzepnica, PolandSPZOZ MSWiA z Warminsko-Mazurskim Centrum Onkologii, Olsztyn, PolandWojewódzki Szpital Specjalistyczny w Olsztynie, Olsztyn, PolandCentrum Onkologii Instytut im Marii Sklodowskiej-Curie, Warsaw, PolandSzpital Specjalistyczny im. Swietej Rodziny SPZOZ, Warsaw, PolandChemotherapy Department, Russian Cancer Research Centre, Moscow, RussiaLeningrad Regional Oncology Dispensary, Saint Petersburg, RussiaSt.Petersburg City Oncology Dispensary, Dept. Gynecology, Saint Petersburg, RussiaAsan Medical Center, Seoul, South KoreaGangnam Severance Hospital, Seoul, South KoreaSamsung Medical Center, Seoul, South KoreaSeoul National University Hospital, Seoul, South KoreaBarcelona,H.Clinic i Provincial,Oncología, Barcelona, SpainBarcelona,H.de la Sta.Creu i S.Pau,Oncología, Barcelona, SpainCórdoba,H.Reina Sofía,Oncología, Córdoba, SpainGerona,H.Josep Trueta,Oncología, Girona, SpainMadrid, H.C.S.Carlos,Oncología, Madrid, SpainMadrid,H.12 de Octubre,Oncología, Madrid, SpainHospital Provincial de Navarra, Pamplona, SpainValencia, IVO, Oncología, Valencia, SpainValencia,H.C.U.Valencia,Oncología, Valencia, SpainCity Hospital Birmingham Cancer Trials Team, Birmingham, United KingdomAddenbrooke's Hospital, Cambridge, United KingdomArden Cancer Centre, Coventry, United KingdomEdinburgh Cancer Research UK Centre, Edinburgh, United KingdomCancer Research UK and UCL Cancer Trials Centre, London, United KingdomRoyal Marsden Hospital, London, United KingdomThe Christie NHS Foundation Trust, Manchester, United KingdomRoyal Marsden Hospital and Institute of Cancer Research, Sutton, United Kingdom